JP2023516494A5 - - Google Patents

Info

Publication number
JP2023516494A5
JP2023516494A5 JP2022554529A JP2022554529A JP2023516494A5 JP 2023516494 A5 JP2023516494 A5 JP 2023516494A5 JP 2022554529 A JP2022554529 A JP 2022554529A JP 2022554529 A JP2022554529 A JP 2022554529A JP 2023516494 A5 JP2023516494 A5 JP 2023516494A5
Authority
JP
Japan
Application number
JP2022554529A
Other languages
Japanese (ja)
Other versions
JP2023516494A (ja
JPWO2021183370A5 (https=
JP7796032B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/020992 external-priority patent/WO2021183370A1/en
Publication of JP2023516494A publication Critical patent/JP2023516494A/ja
Publication of JP2023516494A5 publication Critical patent/JP2023516494A5/ja
Publication of JPWO2021183370A5 publication Critical patent/JPWO2021183370A5/ja
Priority to JP2025272737A priority Critical patent/JP2026040565A/ja
Application granted granted Critical
Publication of JP7796032B2 publication Critical patent/JP7796032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022554529A 2020-03-11 2021-03-05 免疫調節活性を持つ化合物およびその治療的使用 Active JP7796032B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025272737A JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062987914P 2020-03-11 2020-03-11
US62/987,914 2020-03-11
PCT/US2021/020992 WO2021183370A1 (en) 2020-03-11 2021-03-05 Compounds with immunomodulatory activity and therapeutic uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025272737A Division JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Publications (4)

Publication Number Publication Date
JP2023516494A JP2023516494A (ja) 2023-04-19
JP2023516494A5 true JP2023516494A5 (https=) 2024-03-12
JPWO2021183370A5 JPWO2021183370A5 (https=) 2024-03-12
JP7796032B2 JP7796032B2 (ja) 2026-01-08

Family

ID=77671929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022554529A Active JP7796032B2 (ja) 2020-03-11 2021-03-05 免疫調節活性を持つ化合物およびその治療的使用
JP2025272737A Pending JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025272737A Pending JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Country Status (7)

Country Link
US (1) US12448359B2 (https=)
EP (1) EP4117647A4 (https=)
JP (2) JP7796032B2 (https=)
CN (1) CN115551497B (https=)
CA (1) CA3175848A1 (https=)
MX (1) MX2022011171A (https=)
WO (1) WO2021183370A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021183370A1 (en) 2020-03-11 2021-09-16 Purdue Research Foundation Compounds with immunomodulatory activity and therapeutic uses thereof
US12159227B2 (en) * 2020-03-13 2024-12-03 Korea University Research And Business Foundation System for predicting optical properties of molecules based on machine learning and method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2787844C (en) 2010-02-03 2019-08-27 Biomarin Pharmaceutical Inc. Dihydropyridophthalazinone inhibitors of poly(adp-ribose) polymerase (parp) for use in treatment of diseases associated with a pten deficiency
JP6417419B2 (ja) 2013-09-04 2018-11-07 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 免疫調節剤として有用な化合物
US9850225B2 (en) * 2014-04-14 2017-12-26 Bristol-Myers Squibb Company Compounds useful as immunomodulators
EP3190103A1 (en) 2016-01-08 2017-07-12 Rijksuniversiteit Groningen Inhibitors of the pd-1/pd-l1 protein/protein interaction
TWI727010B (zh) 2016-03-10 2021-05-11 日商新日本理化股份有限公司 粉狀1, 4-環己二羧酸
JP7423598B2 (ja) * 2018-04-12 2024-01-29 メドイミューン・リミテッド がんの治療で使用するためのlif阻害剤とpd-1軸阻害剤との組み合わせ
WO2021183370A1 (en) 2020-03-11 2021-09-16 Purdue Research Foundation Compounds with immunomodulatory activity and therapeutic uses thereof

Similar Documents

Publication Publication Date Title
CN305527701S (https=)
CN305710627S (https=)
CN305531935S (https=)
CN305532071S (https=)
CN305539124S (https=)
CN305541858S (https=)
CN305571059S (https=)
CN305575168S (https=)
CN305577230S (https=)
CN305577400S (https=)
CN305581568S (https=)
CN305593888S (https=)
CN305594911S (https=)
CN305606033S (https=)
CN305608377S (https=)
CN305609941S (https=)
CN305635831S (https=)
CN305635905S (https=)
CN305636564S (https=)
CN305637947S (https=)
CN305639652S (https=)
CN305645148S (https=)
CN305654811S (https=)
CN305681768S (https=)
CN305684362S (https=)